$8.03
-0.39-4.63%
At close: Nov 11, 4:00 PM EST
$9.25
0.839.86%
Pre-Market: 7:16 AM EST
SELLAS Life Sciences Group Inc (SLS) Stock Price, Quote, News & History
SLSNASDAQ
SELLAS Life Sciences Group shares are falling Wednesday as the company's Phase 3 leukemia study moves toward its final analysis.
You can purchase shares of SELLAS Life Sciences Gr (NASDAQ:SLS) through any online brokerage.
Other companies in SELLAS Life Sciences Gr’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
SELLAS Life Sciences Gr has a consensus price target of $6.50.
The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $9.25 last updated November 13, 2026 at 7:16 AM EST.
There are no upcoming dividends for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr does not have any upcoming earnings scheduled.
There is no upcoming split for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a...
